Mesoblast (MEOBF) Other Operating Expenses (2014 - 2023)

Mesoblast has disclosed Other Operating Expenses across 10 years of filings, most recently posting $972000.0 for Q2 2023.

• In Q2 2023, Other Operating Expenses rose 285.5% year-over-year to $972000.0; the TTM figure through Jun 2023 stood at $4.0 million (up 851.58% YoY), while the FY2026 annual figure was $5.3 million, up 73.86% from the prior year.
• Other Operating Expenses came in at $972000.0 for Q2 2023 at Mesoblast, down from $3.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $3.3 million in Q1 2023 to a low of -$524000.0 in Q2 2022.
• Average Other Operating Expenses over 5 years is $277411.8, with a median of $99000.0 recorded in 2020.
• Year-over-year, Other Operating Expenses slumped 471.63% in 2022 and surged 746.17% in 2023.
• Over 5 years, Other Operating Expenses stood at $375000.0 in 2019, then dropped by 21.07% to $296000.0 in 2020, then sank by 176.69% to -$227000.0 in 2021, then soared by 210.57% to $251000.0 in 2022, then surged by 287.25% to $972000.0 in 2023.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $972000.0 in Q2 2023, $3.3 million in Q1 2023, and $251000.0 in Q4 2022.